National Research Corporation (NRC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for National Research Corporation (NRC:NASDAQ), powered by AI.

Current Price
$18.47
P/E Ratio
35.6
Market Cap
413M
Sector
Healthcare
What is the National Research Corporation stock price forecast?

National Research Corporation is currently trading at $18.47. View real-time AI analysis on Alpha Lenz.

What is National Research Corporation insider trading activity?

View the latest insider trading data for National Research Corporation on Alpha Lenz.

What is National Research Corporation's P/E ratio?

National Research Corporation's P/E ratio is 35.6.

National Research Corporation

NASDAQ · NRC
$18.47+0.16(+0.87%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about National Research Corporation's future dividend policy...
Alpha Chat Insight

National Research Corporation trades at a P/E of 35.6 (premium valuation) with strong ROE of 51.2%.

Ask for details

Company Overview

National Research Corporation is a prominent organization specializing in healthcare data analytics and insights. Its primary function is to provide comprehensive survey-based analytics and tools that support healthcare systems, medical practices, and businesses in understanding patient experiences and improving care quality. National Research Corporation plays a vital role in the healthcare industry by delivering actionable intelligence that influences how healthcare providers engage with patients and foster improvement across various healthcare delivery areas. The company's services extend across numerous healthcare sectors, including hospitals, health plans, and post-acute care services. National Research Corporation is integral to refining strategies for patient engagement, clinical outcomes, and operational efficiency. Its reputation is built on empowering healthcare organizations with reliable data and insights, aiding these institutions in navigating the complexities of patient-centered care amidst evolving industry standards and regulations. Through its diverse range of products, the corporation remains essential to the transformation and improvement of patient care and satisfaction within the healthcare market.

CEOMr. Trent Green
SectorHealthcare
IndustryHealth Information Services
Employees368

Company Statistics

FY 2025

Profile

$413.41MMarket Cap
$137.39MRevenue
0.00Shares Out
368Employees

Margins

61.88%Gross
22.00%EBITDA
16.44%Operating
12.99%Pre-Tax
8.44%Net

Valuation

35.64P/E
29.55P/B
3.01EV/Sales
16.15EV/EBITDA
26.26P/FCF

Growth (CAGR)

-3.22%Rev 3Yr
0.61%Rev 5Yr
-21.41%Op Inc 3Yr
-11.73%Op Inc 5Yr
-28.55%Net Inc 3Yr
-20.82%Net Inc 5Yr

Returns

8.68%ROA
51.24%ROE
16.91%ROIC

Financial Health

$4.14MCash & Cash Equivalents
$116.75MNet Debt
864.10%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

National Research Corporation (ticker: NRC) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 368 employees. Market cap is $413M.

The current price is $18.47 with a P/E ratio of 35.64x and P/B of 29.55x.

ROE is 51.24% and operating margin is 16.44%. Annual revenue is $137M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
National Research Corporation (NRC) Stock Forecast 2026 $18.47 — Price, Financials & Analyst Targets | Alpha Lenz